About HI-Bio
Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
South San Francisco, United States
Year Founded
2021
Team Size
11–50 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
hibio.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@HIBiosciences
(48 followers)
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $95,000,000 · Series-B
Backed by Alpha Wave Global
- Capital Raise
Raised $120,000,000 · Series-A
Backed by ARCH Venture Partners
- Milestone
Company founded
South San Francisco, United States
Investors & Backers
Alpha Wave Global
Lead
ARCH Venture Partners
Lead
Arkin Capital
Jeito Capital
Monograph Capital
MorphoSys
Viking Global Investors
Funding History
Series-B equity
· Jan 4, 2024
Round backers: Alpha Wave Global
$95,000,000 fundraisingfox.com
Series-A equity
· Nov 1, 2022
Round backers: ARCH Venture Partners
$120,000,000 vcnewsdaily.com
Founders & Leadership
Ariella Kelman
Senior Vice President of Development
Work email & phone locked
Unlock →
Carl Enell
Chief Business Officer
Work email & phone locked
Unlock →
Joyce Liaw
Vice President of Finance
Work email & phone locked
Unlock →
Lorna Dean
Vice President of Clinical Operations
Work email & phone locked
Unlock →
Matthew Albert
Chief Translational Officer
Work email & phone locked
Unlock →
Travis Murdoch
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026